CME LONDON LIMITED

Active London

Administration of financial markets

0 employees website.com
Administration of financial markets
C

CME LONDON LIMITED

Administration of financial markets

Founded 26 Mar 2018 Active London, United Kingdom 0 employees website.com
Administration of financial markets
Accounts Submitted 22 Sept 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 2 Apr 2026 Next due 8 Apr 2027 11 months remaining
Net assets £2,044M £36M 2024 year on year
Total assets £2,961M £52M 2024 year on year
Total Liabilities £917M £16M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

London Fruit And Wool Exchange 1 Duval Square London E1 6PW United Kingdom

Full company profile for CME LONDON LIMITED (11276290), an active company based in London, United Kingdom. Incorporated 26 Mar 2018. Administration of financial markets. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2018–2024)

Cash in Bank

£10.14M

Increased by £9.45M (+1366%)

Net Assets

£2043.65M

Increased by £35.87M (+2%)

Total Liabilities

£917.48M

Increased by £15.78M (+2%)

Turnover

£376.93M

Increased by £50.87M (+16%)

Employees

N/A

Debt Ratio

31%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 3,075 Shares £4609.04m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
1 Oct 201976$101.29m$1.33m
2 Nov 20181,000$1393.00m$1.39m
2 Nov 20181,000$3114.75m$3.11m
24 Oct 2018999£999£1

Officers

Officers

1 active 2 resigned
Status
Richard Joseph BodnumDirectorAmericanUnited States594 Oct 2023Active

Shareholders

Shareholders (1)

Cme Group Inc
NaN%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Cme Group Inc

United States Of America

Active
Notified 26 Mar 2018
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

CME LONDON LIMITED Current Company
NEX GROUP LIMITED united kingdom
EBS INVESTMENTS united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
2 Apr 2026Confirmation StatementConfirmation statement made on 25 Mar 2026 with no updates
6 Feb 2026OfficersAppointment of Andrew John Sikora as director on 5 Feb 2026
13 Jan 2026OfficersTermination of Richard Joseph Bodnum as director on 31 Dec 2025
22 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
1 Apr 2025Confirmation StatementConfirmation statement made on 25 Mar 2025 with no updates
2 Apr 2026 Confirmation Statement

Confirmation statement made on 25 Mar 2026 with no updates

6 Feb 2026 Officers

Appointment of Andrew John Sikora as director on 5 Feb 2026

13 Jan 2026 Officers

Termination of Richard Joseph Bodnum as director on 31 Dec 2025

22 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

1 Apr 2025 Confirmation Statement

Confirmation statement made on 25 Mar 2025 with no updates

Recent Activity

Latest Activity

Confirmation statement made on 25 Mar 2026 with no updates

1 months ago on 2 Apr 2026

Appointment of Andrew John Sikora as director on 5 Feb 2026

3 months ago on 6 Feb 2026

Termination of Richard Joseph Bodnum as director on 31 Dec 2025

3 months ago on 13 Jan 2026

Annual accounts made up to 31 Dec 2024

7 months ago on 22 Sept 2025

Confirmation statement made on 25 Mar 2025 with no updates

1 years ago on 1 Apr 2025